Bacteriology of Hidradenitis Suppurativa – Which Antibiotics are the Treatment of Choice?
DOI:
https://doi.org/10.2340/00015555-1841Keywords:
hidradenitis suppurativa, acne inversa, antibiotics, bacteria, treatment.Abstract
The bacterial superinfection in hidradenitis suppurativa (HS), although it does not initiate the disease itself, seems to be one of the major contributors to an inflammatory vicious circle. Antibiotic therapy is therefore commonly prescribed in HS. This study was undertaken to evaluate the prescription of systemic antibiotics in the light of bacteriological cultures and antibiograms. The study was conducted on a group of 69 patients with HS. The huge majority (n=62) of the patients were treated with antibiotics. The antibiotics were prescribed 132 times and taken for a mean period of 9.9–8.9 weeks. The most commonly used antibiotic was doxycycline (16.7%). The majority of the patients had a polymicrobial flora with up to 5 species, predominantly staphylococci and bacteria of intestinal flora. The highest effectiveness against isolates was observed for carbapanems, penicillins with-lactamase inhibitors and fluoroquinolones – 8.5%, 11.9%, and 11.9% of resistant strains, respectively. In daily practice penicillins with-lactamase inhibitors or fluoroquinolones could serve as first-line therapy of HS.Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 Łukasz Matusiak, Andrzej Bieniek, Jacek C. Szepietowski

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.